Your browser doesn't support javascript.
loading
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment.
Kreft, Karim L; Robertson, Neil P.
Affiliation
  • Kreft KL; Department of Neurology, University Hospital Wales, Cardiff, CF14 4XN, UK.
  • Robertson NP; Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK. robertsonnp@cardiff.ac.uk.
J Neurol ; 269(9): 5192-5193, 2022 09.
Article in En | MEDLINE | ID: mdl-35913607
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Neurol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Neurol Year: 2022 Document type: Article Affiliation country: Country of publication: